Highlights from the 2014 HemOnc Today Melanoma and Cutaneous Malignancies meeting

  • April 21, 2014

NEW YORK — Sanjiv S. Agarwala, MD, highlights the topics covered at the HemOnc Today Melanoma and Cutaneous Malignancies meeting including surgical treatments, therapy, metastatic disease and even non-melanoma cutaneous malignancies.

The 2014 meeting highlighted new research and advances in oncology, dermatology and cutaneous malignancies, including discussions of immunotherapy with ipilimumab, anti-P1 antibodies, targeted therapy for patients with BRAF mutations, combination therapies of BRAF and a MEK inhibitor, immunotherapy with IL-2 and injectable therapies.

More »

Additional headlines from HemOnc Today Melanoma and Cutaneous Malignancies meeting

See All »